Mount Sinai Brooklyn Expands Cancer Services, Infusion Center in $4 Million Project

Also installs high-tech MRI scanner to serve broader set of patients

Mount Sinai Brooklyn Infusion Center/Breast Center Opening Event

NEW YORK, May 19, 2023 (GLOBE NEWSWIRE) — The Mount Sinai Health System today held a grand opening of the expansion of the Mount Sinai Brooklyn Ambulatory Infusion Center, a cancer treatment center that brings innovative cancer therapy and clinical trials to residents of southern Brooklyn.

The $4.1 million expansion doubles the center’s capacity to 15 infusion chairs, seven exam rooms and a mammography suite, offering medical oncology, chemotherapy, therapeutic infusion treatments, consultations, and blood transfusions. Experts in breast cancer, gastrointestinal cancer, gynecological cancer, multiple myeloma, and lung and thoracic cancer treat thousands of Brooklynites every year.

Mount Sinai Brooklyn also announced the addition of a high-tech magnetic resonance imaging (MRI) scanner at the hospital, at a total cost of $2.8 million including installation. A grant from the New York City Council covered the cost of the scanner, $988,000. This new scanner uses artificial intelligence to provide the highest-quality images. The MRI has a larger tube that can accommodate patients of all sizes and is more comfortable for patients who are claustrophobic.

“These new enhancements to Mount Sinai Brooklyn are a reflection of the outstanding commitment that we have made to provide the highest quality of care to all patients and our community,” said Scott Lorin, MD, MBA, President of Mount Sinai Brooklyn. “Exceptional cancer care often requires dynamic multidisciplinary teams to tailor personalized treatment plans, and offering the highest level of care near a patient’s home gives patients access to the best outcomes possible as well as a better quality of life during treatment. Additionally, we are particularly grateful to the City Council for their generous contribution for the MRI scanner that furthers our mission of serving our patients equitably.”

An extension of the Mount Sinai Tisch Cancer Center and The Tisch Cancer Institute, the National Cancer Institute-designated cancer center at the Icahn School of Medicine at Mount Sinai, the Mount Sinai Brooklyn Ambulatory Infusion Center gives patients access to the latest treatment options, medication protocols, and clinical trials.

“The expansion of the infusion center in particular underscores our comprehensive breadth of high quality cancer services available in Brooklynites’ backyard,” said Arvind Kamthan, MD, Chief of Hematology and Medical Oncology for Mount Sinai Brooklyn. “We are continuing to invest in our community and enhancing our health care services.”

Luis Isola, MD, Director of Cancer Clinical Programs and Medical Director of Mount Sinai Cancer Network, added, “Mount Sinai Brooklyn Ambulatory Infusion Center is a demonstration of Mount Sinai’s commitment to delivering outstanding cancer care to local New York communities. We are happy to have expanded our ability to offer Brooklyn residents streamlined access to care from Mount Sinai’s outstanding oncologists in a broad array of specialties.”

A ribbon-cutting ceremony was held on Thursday, May 18, from 11 am to 1 pm with Mount Sinai executives, community leaders, physicians, and patients. As part of the celebration, Mount Sinai Brooklyn offered onsite screenings for residents at the Mount Sinai Health System Mammogram Mobile Unit and the Mount Sinai Robert F. Smith Mobile Prostate Cancer Screening Unit.

Mount Sinai Brooklyn Ambulatory Infusion Center is located at 3131 Kings Highway, Suite 1-02, Brooklyn, NY 11234. To learn more or to schedule an appointment, visit the website.

About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report‘s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Media Contact: Marlene Naanes, marlene.naanes@mountsinai.org

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e4bb7c3a-ea6f-4239-a230-f2db5eea679d

The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.